Open Access

[Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways

  • Authors:
    • Kang Kang
    • Jing Zhang
    • Xiaoyun Zhang
    • Zhao Chen
  • View Affiliations

  • Published online on: January 23, 2023     https://doi.org/10.3892/or.2023.8488
  • Article Number: 51
  • Copyright : © Kang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that various panels showing data from flow cytometric experiments in Figs. 2D, 5D and 6D, and the cell migration and invasion assay data shown in Fig. 2C and 5C, were strikingly similar to data appearing in different form in other articles by different authors. Moreover, the data appeared to be overlapping comparing between a pair of the panels in Figs. 2C and 5C, such that these may have been selected from the same original source, even though the data were intended to show the results from differently performed experiments. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, elsewhere when it was submitted to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 39: 401‑410, 2018; DOI: 10.3892/or.2017.6074]

Related Articles

Journal Cover

March-2023
Volume 49 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kang K, Zhang J, Zhang X and Chen Z: [Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways. Oncol Rep 49: 51, 2023
APA
Kang, K., Zhang, J., Zhang, X., & Chen, Z. (2023). [Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways. Oncology Reports, 49, 51. https://doi.org/10.3892/or.2023.8488
MLA
Kang, K., Zhang, J., Zhang, X., Chen, Z."[Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways". Oncology Reports 49.3 (2023): 51.
Chicago
Kang, K., Zhang, J., Zhang, X., Chen, Z."[Retracted] MicroRNA‑326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways". Oncology Reports 49, no. 3 (2023): 51. https://doi.org/10.3892/or.2023.8488